Supplementary Table.
Comparisons of survivors and non-survivors [n=32]
| Variable | Survivors [n=17] Mean±SD Median (IQR) No. (%) | Non survivors [n=15] Mean±SD Median (IQR) No. (%) | P |
|---|---|---|---|
| Age in years | 40.1±17.48 | 47.0±16.3 | 0.25 |
| M: F | 13:4 | 10:5 | 0.69 |
| Pulmonary TB | 7 (41.1) | 7 (46.6) | 0.75 |
| Tubercular meningitis | 7 (41.1) | 5 (33.3) | 0.64 |
| Initial invasive ventilation | 2 (11.76) | 7 (46.6) | 0.03* |
| Initial SOFA | 3 ( 2-5) | 7 (4-9) | 0.008* |
| SOFA at 48 h | 4 (3-5) | 6 (5.5-8) | 0.006* |
| Initial inflammatory markers | |||
| IL6 (pg/mL) | 66.02 (18.4-105.7) | 30.5 (19-253) | 0.81 |
| Ferritin (µg/L) | 287.8 (98-567) | 844 (404 - 1500) | 0.04* |
| CRP (mg/dL) | 7.7 (2.3-18.1) | 14.5 (7.8-21.7) | 0.23 |
| Procalcitonin (ng/mL) | 4.4 (0.8-10) | 1.4 (0.2-6.4) | 0.31 |
| Complications | |||
| Pneumothorax | 1 (5.88) | 4 (26.67) | 0.16 |
| Deranged LFT | 5 (29.41) | 5 (33.33) | 1.00 |
| AKI | 4 (23.53) | 6 (40.0) | 0.45 |
| Duration of hospital stay (days) | 14 (9-20) | 9 (4-19) | 0.17 |
*- significant; TB: Tuberculosis, SOFA: Sequential Organ Failure Assessment; IL-6: Interleukin- 6; CRP: C-reactive protein; LFT: liver function test; AKI: acute kidney injury. Data is presented as mean ±SD; median (IQR); No. (%)